The
pancreatic peptide hormone insulin, first discovered exactly
100 years ago, is essential for glycemic control and is used as a
therapeutic for the treatment of type 1 and, increasingly, type 2
diabetes. With a worsening global diabetes epidemic and its significant
health budget imposition, there is a great demand for new analogues
possessing improved physical and functional properties. However, the
chemical synthesis of insulin’s intricate 51-amino acid, two-chain,
three-disulfide bond structure, together with the poor physicochemical
properties of both the individual chains and the hormone itself, has
long represented a major challenge to organic chemists. This review
provides a timely overview of the past efforts to chemically assemble
this fascinating hormone using an array of strategies to enable both
correct folding of the two chains and selective formation of disulfide
bonds. These methods not only have contributed to general peptide
synthesis chemistry and enabled access to the greatly growing numbers
of insulin-like and cystine-rich peptides but also, today, enable
the production of insulin at the synthetic efficiency levels of recombinant
DNA expression methods. They have led to the production of a myriad
of novel analogues with optimized structural and functional features
and of the feasibility for their industrial manufacture.